Natixis’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1
| Closed | -$29 | – | 1007 |
|
2024
Q2 | $29 | Hold |
1
| – | – | ﹤0.01% | 955 |
|
2024
Q1 | $21 | Sell |
1
-15,926
| -100% | -$334K | ﹤0.01% | 969 |
|
2023
Q4 | $431K | Buy |
+15,927
| New | +$431K | ﹤0.01% | 618 |
|
2023
Q3 | – | Sell |
-22,837
| Closed | -$818K | – | 1029 |
|
2023
Q2 | $818K | Buy |
+22,837
| New | +$818K | 0.01% | 565 |
|
2022
Q4 | – | Sell |
-24,503
| Closed | -$1.35M | – | 1103 |
|
2022
Q3 | $1.35M | Sell |
24,503
-37,118
| -60% | -$2.05M | 0.01% | 659 |
|
2022
Q2 | $2.49M | Buy |
61,621
+26,334
| +75% | +$1.07M | 0.01% | 586 |
|
2022
Q1 | $2.34M | Sell |
35,287
-28,953
| -45% | -$1.92M | 0.01% | 720 |
|
2021
Q4 | $6.43M | Buy |
64,240
+25,605
| +66% | +$2.56M | 0.02% | 501 |
|
2021
Q3 | $4.83M | Sell |
38,635
-11,973
| -24% | -$1.5M | 0.02% | 548 |
|
2021
Q2 | $6.29M | Buy |
50,608
+6,228
| +14% | +$773K | 0.03% | 343 |
|
2021
Q1 | $6.78M | Sell |
44,380
-9,681
| -18% | -$1.48M | 0.02% | 452 |
|
2020
Q4 | $6.97M | Buy |
54,061
+3,606
| +7% | +$465K | 0.03% | 459 |
|
2020
Q3 | $5.64M | Sell |
50,455
-7,154
| -12% | -$800K | 0.04% | 253 |
|
2020
Q2 | $4.67M | Buy |
+57,609
| New | +$4.67M | 0.04% | 303 |
|
2019
Q4 | – | Sell |
-392,765
| Closed | -$25.1M | – | 879 |
|
2019
Q3 | $25.1M | Buy |
392,765
+374,813
| +2,088% | +$23.9M | 0.16% | 134 |
|
2019
Q2 | $1.55M | Sell |
17,952
-65,713
| -79% | -$5.67M | 0.01% | 477 |
|
2019
Q1 | $6.17M | Buy |
+83,665
| New | +$6.17M | 0.04% | 350 |
|